If you are still having problems viewing this message, please click here for additional help.

Bone Marrow Transplantation

Scientific Reports Editor's choice collection: Transplantation Transferring a tissue or organ from one individual to another remains one of the most challenging and complex medical endeavours. This collection brings together transplantation research recently published in Scientific Reports, with a focus on the most commonly transplanted organs.
Access the collection >>>

Volume 53, Issue 7

In this issue
Also new


Sex matters

Shaun McCann

Bone Marrow Transplantation 2018 53 :805 - 806; July 04, 2018; 10.1038/s41409-018-0186-5


Abstract | Full Text


Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation

Stella Robert, Jörn C. Albring, Karin Frebel, Corinna Opitz, Jennifer Urh et al.

Bone Marrow Transplantation 2018 53 :807 - 819; January 23, 2018; 10.1038/s41409-017-0071-7


Abstract | Full Text

Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients

Flavio Gössi, Martin Spahn, Panagiotis Samaras, Jörg Beyer, Julian Schardt et al.

Bone Marrow Transplantation 2018 53 :820 - 825; January 24, 2018; 10.1038/s41409-018-0089-5


Abstract | Full Text

Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

Hanna Jean Khoury, Amelia A. Langston, Vamsi K. Kota, Jennifer A. Wilkinson, Iskra Pusic et al.

Bone Marrow Transplantation 2018 53 :826 - 831; January 24, 2018; 10.1038/s41409-017-0081-5


Abstract | Full Text

Biomarkers in chronic graft-versus-host disease: quo vadis?

D. Wolff, H. Greinix, S. J. Lee, T. Gooley, S. Paczesny et al.

Bone Marrow Transplantation 2018 53 :832 - 837; January 24, 2018; 10.1038/s41409-018-0092-x


Abstract | Full Text

Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes

Noura Alhashim, Mahmoud Aljurf, Mona Hassanein, Naeem Chaudhri, Shahrukh Hashmi et al.

Bone Marrow Transplantation 2018 53 :838 - 843; January 25, 2018; 10.1038/s41409-018-0093-9


Abstract | Full Text

Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival

Marietta Nygaard, Niels Smedegaard Andersen, Claus Ernst Moser, Gitte Olesen, Ida Marie Schjødt et al.

Bone Marrow Transplantation 2018 53 :844 - 851; February 01, 2018; 10.1038/s41409-018-0099-3


Abstract | Full Text

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, Oliver Basu, Gesine Bug et al.

Bone Marrow Transplantation 2018 53 :852 - 862; January 29, 2018; 10.1038/s41409-018-0102-z


Abstract | Full Text

Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation

Meeta Pathak, Phoi Phoi Diep, Xiaoran Lai, Lorentz Brinch, Ellen Ruud et al.

Bone Marrow Transplantation 2018 53 :863 - 872; January 30, 2018; 10.1038/s41409-018-0090-z


Abstract | Full Text

Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: A National Cancer Database Study

Vijaya Raj Bhatt, Baojiang Chen & Stephanie J. Lee

Bone Marrow Transplantation 2018 53 :873 - 879; February 05, 2018; 10.1038/s41409-018-0105-9


Abstract | Full Text

Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial

H. Ozdogu, C. Boga, M. Yeral, I. Kozanoglu, C. Gereklioglu et al.

Bone Marrow Transplantation 2018 53 :880 - 890; February 05, 2018; 10.1038/s41409-018-0111-y


Abstract | Full Text


Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial

Michael Merker, Michael Torsten Meister, Eva Rettinger, Andrea Jarisch, Jan Soerensen et al.

Bone Marrow Transplantation 2018 53 :891 - 894; January 24, 2018; 10.1038/s41409-018-0088-6


Abstract | Full Text

Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy

Rouslan Kotchetkov, Anna Dyszkiewicz-Korpanty & Vishal Kukreti

Bone Marrow Transplantation 2018 53 :895 - 899; January 24, 2018; 10.1038/s41409-017-0080-6


Abstract | Full Text

Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease

Alexander Coltoff, Guido Lancman, Sara Kim & Amir Steinberg

Bone Marrow Transplantation 2018 53 :900 - 904; January 25, 2018; 10.1038/s41409-018-0094-8


Abstract | Full Text

Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis

Shigeo Fuji, Saiko Kurosawa, Yoshihiro Inamoto, Tatsunori Murata, Atae Utsunomiya et al.

Bone Marrow Transplantation 2018 53 :905 - 908; January 25, 2018; 10.1038/s41409-017-0082-4


Abstract | Full Text

‘To treat or not to treat’: raising awareness on the effects of graft versus host disease drugs on musculoskeletal system

Jaleel Mohammed, Tola Akomolafe, Mahmoud Aljurf, Bipin Savani & Shahrukh K. Hashmi

Bone Marrow Transplantation 2018 53 :909 - 912; January 25, 2018; 10.1038/s41409-018-0095-7


Abstract | Full Text

Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy

Valeria Calbi, Francesca Fumagalli, Giulia Consiglieri, Rachele Penati, Serena Acquati et al.

Bone Marrow Transplantation 2018 53 :913 - 917; January 29, 2018; 10.1038/s41409-017-0085-1


Abstract | Full Text

Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation

Marie-Joelle Apithy, Amandine Charbonnier, Judith Desoutter, Momar Diouf, Pierre Morel et al.

Bone Marrow Transplantation 2018 53 :918 - 922; January 29, 2018; 10.1038/s41409-017-0083-3


Abstract | Full Text

High-dose methylprednisolone for the treatment of sinusoidal obstruction syndrome in adults

Mantas Vaisvilas, Skirmante Buseckaite, Orinta Mickeviciute, Rita Cekauskiene, Laimonas Griskevicius et al.

Bone Marrow Transplantation 2018 53 :923 - 925; January 29, 2018; 10.1038/s41409-018-0087-7


Abstract | Full Text

Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia

Gemma Dyer, Lisa Brice, Nicole Gilroy, Masura Kabir, Mark Hertzberg et al.

Bone Marrow Transplantation 2018 53 :926 - 931; January 29, 2018; 10.1038/s41409-018-0098-4


Abstract | Full Text

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

Lucie M. Turcotte, Tao Wang, Michael T. Hemmer, Stephen R. Spellman, Mukta Arora et al.

Bone Marrow Transplantation 2018 53 :932 - 937; January 30, 2018; 10.1038/s41409-018-0100-1


Abstract | Full Text

The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant

Hafsat Mashegu, Laura Smith, Yimei Li, Alix Seif, Stephan Grupp et al.

Bone Marrow Transplantation 2018 53 :938 - 941; February 06, 2018; 10.1038/s41409-018-0113-9


Abstract | Full Text

Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation

Alisha Pandit, Houry Leblebjian, Sarah P. Hammond, Jacob P. Laubach, Paul G. Richardson et al.

Bone Marrow Transplantation 2018 53 :942 - 945; February 09, 2018; 10.1038/s41409-018-0112-x


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature